Pharmacy Medical News about Antiviral Agents

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Investment in antiviral drugs: a real options approach
Health Economics, 10/29/09

Feenstra TL et al. – The authors provide a numerical example using real world data and discuss the implications of real options analysis for health policy. Suggestions for further extensions of the model and a comparison with the expected value of information analysis are put forward.

<< Previous
A novel method for determining the inhibitory potential of...

Next >>
The role of surveillance in the treatment of patients with...

Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options
Current Drug Targets, 10/23/09 Relevance Score: 69%

Viral Adaptation to an Antiviral Protein Enhances the Fitness Level to Above That of the Uninhibited Wild Type
Journal of Virology, 11/12/09 Relevance Score: 67%

The next ten stories on antiviral drug discovery (part E): Advents, Advances, and Adventures
Medicinal Research Reviews, 10/21/09 Relevance Score: 66%

The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2alpha Via Protein Kinase Activated by Double-Stranded RNA Activation
Gastroenterology, 10/29/09 Relevance Score: 65%

Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic
Annals of Internal Medicine, 10/13/09 Relevance Score: 65%